XP stock closes 3.61% higher, but daily MACD still trails its signal

XP stock has a bullish daily structure, but momentum does not offer an unqualified endorsement. Price stands above all three daily exponential averages. However, the daily MACD line sits below its signal, while the hourly chart provides only partial confirmation of the bullish bias.

Key takeaways

• XP stock ended Friday’s session at $30.41, 3.61% above the prior close. A search of recent coverage found no company-specific news.
• Daily averages are aligned bullishly: the 20-session EMA at $28.1, 50-session at $24.09, and 200-session at $19.79 all sit below price.
• Daily RSI14 is 65.05 and the daily MACD line at 2.5 sits below its signal at 2.73, producing a negative histogram of -0.23.
• The daily pivot for the next session is $29.98, with first resistance at $31.07 and first support at $29.32.
• Daily ATR14 reads $1.39, with the session close above the pivot but below both the session high of $30.64 and first resistance.

On Friday, October 23, 2026, XP opened at $29.50, traded between a low of $28.89 and a high of $30.64, and closed at $30.41, against a previous close of $29.35.

XP stock: Daily structure supports a qualified bullish case

The daily averages are bullishly aligned beneath price. The 20-session EMA is $28.1, followed by the 50-session at $24.09 and the 200-session at $19.79. That complete ordering supports the main bullish thesis. Price also stands above the daily Bollinger mid-band at $27.98 and below the upper band at $36.47.

However, the momentum readings are mixed. Daily RSI14 is 65.05, above 50 but below overbought territory. The MACD line is positive at 2.5, yet below its signal at 2.73. Its negative histogram of -0.23 leaves the daily trend structure without full momentum confirmation.

Meanwhile, daily ATR14 reads $1.39, providing a volatility reference for the next session. The bullish average structure does not remove the scope for price movement on that scale.

Hourly confirmation remains incomplete

On the hourly chart, XP stock’s session close stands above the 20-hour EMA at $29.89. It also sits above the 50-hour EMA at $30 and the 200-hour EMA at $26.54. Nevertheless, the 20-hour average sits below the 50-hour average, so the ordering is not fully bullish. Price is also above the hourly Bollinger mid-band at $29.8 and below its upper band at $31.13.

Hourly RSI14 is 56.67, on the positive side of 50. The hourly MACD line is negative at -0.09 but above its signal at -0.22, producing a positive histogram of 0.13. This offers some support for the daily bullish case, though the line remains below zero.

Short-term timing and next-session levels

15-minute chart provides execution context

At the same time, the 15-minute chart offers execution context rather than a separate directional thesis. The session close stands above its 200-period EMA at $30.31 and below its upper Bollinger band at $30.72. RSI14 is 67.57, below overbought territory. The MACD line at 0.29 is above its signal at 0.21, with a positive histogram of 0.08. These readings favor the bullish side of short-term timing without resolving the daily MACD conflict.

Pivot levels and next-session scenarios

For trading when the next session resumes, the daily pivot sits at $29.98. First resistance is at $31.07 and first support at $29.32. The $30.41 session close is above that pivot but below first resistance, leaving both levels relevant to the next directional test.

The bullish scenario requires price to hold above the daily pivot at $29.98 and clear the session high at $30.64. A move above daily first resistance at $31.07 would provide further price confirmation. A daily MACD line above its signal would also resolve the principal momentum objection to that case.

In contrast, a break below the daily pivot at $29.98 would put first support at $29.32 in focus. Losing that support would invalidate the immediate bullish setup. A break below the daily 20-session EMA at $28.1 would further weaken the broader bullish reading.

Overall, XP stock stands above its daily averages and next-session pivot, but below the session high and daily first resistance. Daily ATR14 of $1.39 keeps volatility relevant. The unresolved question is whether price can clear resistance while daily momentum supplies the confirmation it currently lacks.

FAQ

What is the daily trend structure for XP stock?

XP stock stands above all three daily exponential averages — the 20-session EMA at $28.1, the 50-session at $24.09, and the 200-session at $19.79 — supporting a bullish structure. However, the daily MACD line at 2.5 sits below its signal at 2.73, leaving momentum confirmation incomplete.

What are the key levels for the next trading session?

The daily pivot is $29.98. First resistance sits at $31.07 and first support at $29.32. The session close at $30.41 is above the pivot but below first resistance.

What is the state of hourly momentum for XP stock?

Hourly RSI14 is 56.67, above the neutral 50. The hourly MACD line is negative at -0.09 but above its signal at -0.22, producing a positive histogram of 0.13. The 20-hour EMA sits below the 50-hour EMA, so the hourly average ordering is not fully bullish.

What would confirm the bullish case for XP stock?

A move above the session high of $30.64 and daily first resistance at $31.07 would provide price confirmation. Additionally, a daily MACD line crossing above its signal at 2.73 would resolve the principal momentum objection.

---

Disclaimer: This article is for informational purposes only and does not constitute financial advice, an investment recommendation, or a solicitation to buy or sell any financial instrument. The analysis provided is not indicative of future results. Investing in financial markets carries a high risk of capital loss. Always do your own research (DYOR) and consult a qualified financial advisor before making any decision.

Cryptonomist and the author hold no positions in the financial instruments mentioned and receive no compensation from the companies covered.

Article produced with the assistance of artificial intelligence and reviewed by the editorial team.